Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report

Ann N Y Acad Sci. 1993 Nov 30:698:398-402. doi: 10.1111/j.1749-6632.1993.tb17232.x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Neutropenia / prevention & control
  • Paclitaxel / therapeutic use*
  • Paclitaxel / toxicity*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Paclitaxel